You are here: Industry Insights > acquision

News List

United States Pharmacopeia Acquires Pharmatech Associates contractpharma
July 12, 2021
Expanded offerings will help regulated life science companies strengthen the supply chain for safe, quality medicines.
Xeris to Acquire Strongbridge Biopharma contractpharma
May 25, 2021
The two businesses will be combined under a new entity called Xeris Biopharma Holdings, specializing in endocrinology and rare diseases.
PerkinElmer Acquires Nexcelom Bioscience contractpharma
May 18, 2021
Bolsters preclinical portfolio and enhances QA/QC capabilities in cell and gene therapy and biologics manufacturing.
PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience americanpharmaceuticalreview
May 14, 2021
PerkinElmer, Inc. is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second quarter of 2021.
Icon to Acquire PRA Health Sciences contractpharma
March 02, 2021
Icon, a company creating a new paradigm for bringing clinical research to patients, has agreed to acquire PRA Health Sciences Inc. in a cash and stock transaction valued at approximately $12 billion.
Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals contractpharma
January 11, 2021
Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.
Grifols to Acquire GC Pharma’s Plasma Facilities for $460M contractpharma
July 21, 2020
Gains Montreal-based plasma fractionation facility, two purification facilities, and 11 U.S.-based plasma collection centers.
Alexion to buy Portola Pharmaceuticals for $1.41bn pharmaceutical-technology
May 07, 2020
Alexion Pharmaceuticals has signed a definitive agreement to acquire Portola Pharmaceuticals for a total consideration of $1.41bn, or $18 per share.